nach oben

Erschienen in:

01.03.2012 | Editorial

Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010

verfasst von: Prof. Dr. R. Sauer, H. Creeze, M. Hulshof, R. Issels, O. Ott, on behalf of the Interdisciplinary Working Group for Clinical Hyperthermia (Atzelsberg Circle) of the German Cancer Society and the German Society of Radiooncology

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Excerpt

The “Final Report” from the Ludwig Boltzmann Institute Vienna (LBI), described as the result of a “systematic review”, takes the report published in 2005 by the German Joint Federal Committee (JFC Report) [1]—the most senior decision-making body for healthcare politics in Germany—and assesses whether evidence has changed for the 11 oncological indicators for hyperthermia (HT) that were classified as promising since the latter was published. The authors state that they also conducted other reviews of the literature in medical databases and in Health Technology Assessment databases [2]. …

GBA Gemeinsamer Bundesausschuss der Bundesrepublik Deutschland: Zusammenfassender Bericht des Unterausschusses “Ärztliche Behandlung” des Gemeinsamen Bundesausschusses über die Bewertung gemäß § 135 Abs. 1 SGB V der Hyperthermie (u. a. Ganzkörper-Hyperthermie, Regionale Tiefenhyperthermie, Oberflächen-Hyperthermie, Hyperthermie in Kombination mit Radiatio und/oder Chemotherapie) (2005), available at http://www.g-ba.de/downloads/40-268-236/2005-06-15-BUB-Hyperthermie.pdf, accessed 27 January 2012

Mathis S, Johnasson T (2010) Hyperthermie. Decision Support Document 36 (2010); Ludwig Boltzmann Institut für Health Technology Assessment (LBI-HTA) ISSN-online: 1992-0496, available at http://eprints.hta.lbg.ac.at, accessed 27 January 2012

Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731–744PubMedCrossRef

Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085PubMedCrossRef

Jones EL, Marks LB, Prosnitz LR (2007) Point: hyperthermia with radiation for chest wall recurrences. J Natl Compr Canc Netw 5:339–344PubMed

Van der Zee J, Rhoon GC van, Wijnmaalen AJ et al (1999) Reirradiatie met hyperthermie bij patiënten met een recidief mammacarcinoom. Ned Tijd Gen 143:80–84

NCCN Clinical Practice Guidelines in Oncology. Breast Cancer: Version 2.2011; available at http://www.nccn.com, accessed 27 January 2012

Conceptrichtlijn mammacarcinoom 2011. Internet: Integraal Kankercentrum Nederland. http://www.oncoline.nl, accessed 27 January 2012

Chen HW, Jun-Jie F, Wei L (1997) A randomized trial of hyper-thermo-radiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 24:249–251

10.

Datta NR, Bose AK, Kapoor HK (1987) Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): a controlled clinical study. Ind Med Gaz 121:68–71

11.

Harima Y, Nagata K, Harima K et al (2001) A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17:97–105PubMedCrossRef

12.

Sharma S, Patel FD, Sandhu APS et al (1989) A prospective randomised study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 5:151–159

13.

Vasanthan A, Mitsumori M, Park JH et al (2005) Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 61:145–153PubMedCrossRef

14.

Lutgens L, Zee J van der, Pijls-Johannesma M et al (2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev DOI 10.1002/14651858.CD006377.pub3

15.

Zee J van der, Gonzalez GD, Rhoon GC van et al (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–1125PubMedCrossRef

16.

Franckena M, Stalpers LJ, Koper PC et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176–1182PubMedCrossRef

17.

Krause FS, Walter B, Ott OJ et al (2010) 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res 31:985–990

18.

Ott OJ, Rodel C, Weiss C et al (2009) Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) 21:557–565

19.

Rodel C, Grabenbauer GG, Kuhn R et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071PubMedCrossRef

20.

Wittlinger M, Rodel CM, Weiss C et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358–363PubMedCrossRef

21.

Colombo R, Da Pozzo LF, Salonia A et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270–4276PubMedCrossRef

22.

Issels R, Lindner LH, Verweij J et al (2010) for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and the European Society for Hyperthermic Oncology (ESHO). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–570PubMedCrossRef

23.

NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma: Version 2.2011; available at http://www.nccn.com, accessed 27 January 2012

24.

Issels RD, Lindner LH, Wust P et al (2007) Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: a phase III randomised prospective trial (EORTC-ESHO Intergroup trial) [abstract 10009]. J Clin Oncol 25(Suppl 18):547

25.

Bruggmoser G, Bauchowitz S, Canters R et al (2011) Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 187:605–610PubMedCrossRef

26.

Zagar TM et al (2010) Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: A review of the randomised data. Int J Hyperthermia 26(7):612–617PubMedCrossRef

27.

Overgaard J, Gonzalez Gonzalez D, Hulshof MC et al (1995) Randomized trial of hyperthermia as an adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345:540–543PubMedCrossRef

28.

Huilgol NG, Gupta S, Sridhar CR (2010) Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther 6(4):492–496PubMedCrossRef

29.

Valdagni R, Amichetti M (1993) Report of longterm follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163–169CrossRef

Titel: Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010
verfasst von: Prof. Dr. R. Sauer
H. Creeze
M. Hulshof
R. Issels
O. Ott
on behalf of the Interdisciplinary Working Group for Clinical Hyperthermia (Atzelsberg Circle) of the German Cancer Society and the German Society of Radiooncology
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 3/2012
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-012-0072-9

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer

Limited disease of extra-pulmonary small cell carcinoma

RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma

Radiation-induced cranial neuropathy in patients with nasopharyngeal carcinoma

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck

High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie